Invitation to Vitrolife Group's presentation of the Q3 2025 interim report
Werte in diesem Artikel
GOTHENBURG, Sweden, Oct. 9, 2025 /PRNewswire/ -- Vitrolife AB (publ) will publish its Q3 2025 interim report on Thursday, 23 October 2025 at 08:00 am CEST. A conference call for investors, analysts and financial media will be held at 10:00 am CEST the same day.
The presentation will be held in English by Bronwyn Brophy O'Connor, CEO, and Pär Ihrskog, CFO. The conference call will begin with a presentation of the report followed by a question-and-answer session. The presentation material will be available prior to the start of the conference call on the Vitrolife Group website www.vitrolifegroup.com.
To follow the webcast, please use this link.
To participate in the conference call please register via this link. After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference.
After the event, the presentation material and a recording of the webcast will be available at www.vitrolifegroup.com. Gothenburg, 9 October 2025
VITROLIFE AB (publ)
Contact:
Amelie Wilson, Investor relations, external corporate communications and executive support, awilson@vitrolife.com
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Invitation to Vitrolife Group's presentation of the Q3 2025 interim report |
View original content:https://www.prnewswire.com/news-releases/invitation-to-vitrolife-groups-presentation-of-the-q3-2025-interim-report-302579476.html
SOURCE Vitrolife AB (publ)
Ausgewählte Hebelprodukte auf Vitrolife Registered
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Vitrolife Registered
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Nachrichten zu Vitrolife AB Registered Shs
Analysen zu Vitrolife AB Registered Shs
Keine Analysen gefunden.